mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.009 |
mRNA |
gossypol |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.009 |
mRNA |
ML320 |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.01 |
mRNA |
PF-4800567 hydrochloride |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.01 |
mRNA |
BRD8958 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.01 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.01 |
mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.01 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.01 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.01 |
mRNA |
SJ-172550 |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.02 |